140 related articles for article (PubMed ID: 1783799)
1. [A mechanism of usefulness of treatment with erythromycin for diffuse panbronchiolitis].
Ichikawa Y; Ninomiya H; Koga H; Tokunaga N; Tanaka Y; Yano T; Oizumi K
Kansenshogaku Zasshi; 1991 Dec; 65(12):1501-7. PubMed ID: 1783799
[TBL] [Abstract][Full Text] [Related]
2. Erythromycin inhibits neutrophil chemotaxis in bronchoalveoli of diffuse panbronchiolitis.
Oda H; Kadota J; Kohno S; Hara K
Chest; 1994 Oct; 106(4):1116-23. PubMed ID: 7924482
[TBL] [Abstract][Full Text] [Related]
3. Leukotriene B4 in bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis.
Oda H; Kadota J; Kohno S; Hara K
Chest; 1995 Jul; 108(1):116-22. PubMed ID: 7606944
[TBL] [Abstract][Full Text] [Related]
4. Erythromycin reduces neutrophils and neutrophil-derived elastolytic-like activity in the lower respiratory tract of bronchiolitis patients.
Ichikawa Y; Ninomiya H; Koga H; Tanaka M; Kinoshita M; Tokunaga N; Yano T; Oizumi K
Am Rev Respir Dis; 1992 Jul; 146(1):196-203. PubMed ID: 1626803
[TBL] [Abstract][Full Text] [Related]
5. A mechanism of erythromycin treatment in patients with diffuse panbronchiolitis.
Kadota J; Sakito O; Kohno S; Sawa H; Mukae H; Oda H; Kawakami K; Fukushima K; Hiratani K; Hara K
Am Rev Respir Dis; 1993 Jan; 147(1):153-9. PubMed ID: 8420410
[TBL] [Abstract][Full Text] [Related]
6. Significance of IL-1beta and IL-1 receptor antagonist (IL-1Ra) in bronchoalveolar lavage fluid (BALF) in patients with diffuse panbronchiolitis (DPB).
Kadota J; Matsubara Y; Ishimatsu Y; Ashida M; Abe K; Shirai R; Iida K; Kawakami K; Taniguchi H; Fujii T; Kaseda M; Kawamoto S; Kohno S
Clin Exp Immunol; 1996 Mar; 103(3):461-6. PubMed ID: 8608647
[TBL] [Abstract][Full Text] [Related]
7. [A study of bronchoalveolar lavage analysis in patients with diffuse panbronchiolitis--the results of low dose and long term erythromycin treatment].
Mukae H; Sakito O; Oda H; Senju R; Hiratani K; Kadota J; Fukushima K; Komori K; Kouno S; Hara K
Kansenshogaku Zasshi; 1991 Jun; 65(6):692-7. PubMed ID: 1919099
[TBL] [Abstract][Full Text] [Related]
8. Neutrophilia and high level of interleukin 8 in the bronchoalveolar lavage fluid of diffuse panbronchiolitis.
Koga T
Kurume Med J; 1993; 40(3):139-46. PubMed ID: 8139213
[TBL] [Abstract][Full Text] [Related]
9. Neutrophil chemotactic activity in bronchoalveolar lavage fluid recovered from patients with diffuse panbronchiolitis.
Katsuki M
Kurume Med J; 1996; 43(4):279-87. PubMed ID: 9029897
[TBL] [Abstract][Full Text] [Related]
10. Neutrophilia in bronchoalveolar lavage fluid of diffuse panbronchiolitis.
Ichikawa Y; Koga H; Tanaka M; Nakamura M; Tokunaga N; Kaji M
Chest; 1990 Oct; 98(4):917-23. PubMed ID: 2209148
[TBL] [Abstract][Full Text] [Related]
11. Increased concentrations of human beta-defensins in plasma and bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis.
Hiratsuka T; Mukae H; Iiboshi H; Ashitani J; Nabeshima K; Minematsu T; Chino N; Ihi T; Kohno S; Nakazato M
Thorax; 2003 May; 58(5):425-30. PubMed ID: 12728165
[TBL] [Abstract][Full Text] [Related]
12. Superoxide dismutase in alveolar macrophages from patients with diffuse panbronchiolitis.
Morikawa T; Kadota JI; Kohno S; Kondo T
Respiration; 2000; 67(5):546-51. PubMed ID: 11070461
[TBL] [Abstract][Full Text] [Related]
13. Long term effect of erythromycin therapy in patients with chronic Pseudomonas aeruginosa infection.
Fujii T; Kadota J; Kawakami K; Iida K; Shirai R; Kaseda M; Kawamoto S; Kohno S
Thorax; 1995 Dec; 50(12):1246-52. PubMed ID: 8553295
[TBL] [Abstract][Full Text] [Related]
14. [Analysis of peripheral lymphocyte subsets and changes due to erythromycin therapy in patients with diffuse panbronchiolitis].
Sugiyama Y; Sugama Y; Takeuchi K; Kudoh S; Kitamura S
Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Dec; 28(12):1574-80. PubMed ID: 2077202
[TBL] [Abstract][Full Text] [Related]
15. [Elastase activity in bronchoalveolar lavage fluid from patients with diffuse panbronchiolitis].
Ninomiya H; Ichikawa Y; Koga H; Yano T; Oizumi K
Kansenshogaku Zasshi; 1991 Jun; 65(6):672-80. PubMed ID: 1919096
[TBL] [Abstract][Full Text] [Related]
16. [Effect of erythromycin on intrapulmonary influx of neutrophils by intratracheal injection of lipopolysaccharide].
Sakito O; Kadota J; Oda H; Mukae H; Yokoyama A; Kawamoto S; Kaseda M; Morikawa T; Kusano S; Asai T
Kansenshogaku Zasshi; 1992 Feb; 66(2):194-200. PubMed ID: 1402080
[TBL] [Abstract][Full Text] [Related]
17. [Determination of the neutrophil chemotactic factor in bronchoalveolar lavage fluid in patients with diffuse panbronchiolitis].
Oda H; Kadota J; Sakito O; Mukae H; Morikawa N; Shukuwa C; Senju R; Sawa H; Kusano S; Morikawa T
Kansenshogaku Zasshi; 1992 Apr; 66(4):441-7. PubMed ID: 1624836
[TBL] [Abstract][Full Text] [Related]
18. The effect of long-term treatment with erythromycin on Th1 and Th2 cytokines in diffuse panbronchiolitis.
Park SJ; Lee YC; Rhee YK; Lee HB
Biochem Biophys Res Commun; 2004 Nov; 324(1):114-7. PubMed ID: 15464990
[TBL] [Abstract][Full Text] [Related]
19. [Effects of erythromycin on H2O2 generation by neutrophils].
Matsumoto K; Sugihara E; Ichikawa Y; Arikawa K; Honda J; Oizumi K
Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Jan; 35(1):3-8. PubMed ID: 9071149
[TBL] [Abstract][Full Text] [Related]
20. New approaches to Pseudomonas aeruginosa lower respiratory tract infections.
Matsumoto K
Verh K Acad Geneeskd Belg; 1995; 57(2):109-22. PubMed ID: 7571853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
